All In MedTech

Device Trial Radar · NCT07145905

TCRM for Correction of Cheek Including Fine Lines

A Prospective, Open-label, Multicenter, Interventional Study, to Evaluate Safety and Efficacy of TCRM in the Treatment of the Cheek Area Including Fine Lines: SPARKS

Last checked: Nov 20, 2026Latest source record: Sep 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

130

Actual

Start

Nov 30, 2023

Primary completion

Sep 30, 2025

Study completion Jan 31, 2026

Sponsor

Lead sponsor
Teoxane SANot on our public-company list
Sponsor type
Industry
First posted
Aug 28, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this clinical study is to evaluate benefits and risks of injecting TCRM in the cheek including fine lines. The goal is to show that treatment with TCRM will result in correcting the cheek area including the fine lines at 4 weeks after last treatment (initial injection or touch up) on subjects.

Conditions

  • Skin Aging
  • Cheek Wrinkles

Interventions

  • TCRMDevice

    N=128

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To demonstrate the efficacy of TCRM in the treatment of the cheek area including fine lines at 4 weeks after last injection (initial injection or touch up) using Global Aesthetic Improvement Scale (GAIS) as assessed by both subject and PI.Time frame: 4 weeks after last injection

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Centro Médico Lajo Rosso

    Madrid, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.